Skip to content

The European Union Falsified Medicines Directive (FMD) is designed to protect public health by securing the pharmaceutical supply chain against counterfeit medicines. It’s a rigorous set of rules that pharmaceutical companies operating in Europe need to abide by, and at Sharp we can help.

Our comprehensive serialisation service can help you meet the criteria demanded by the FMD by making your products fully traceable and trackable through their supply chain.

We’re able to aggregate serial numbers for up to five levels of packaging in multiple formats, from the cavities of our blister packs through to the pallets they ship in, so you’ll always be able to identify where your products are – and where they came from.

Related Resources

Are you attending Korea Pharm & Bio in April?
Connect with Sharp to see how we can help you engineer the best #packagingsolutions for #productlaunch in the US and EU market. #SharpServices #pharmapackaging #biotech #coldchain #serialization

Another big milestone for our #ClinicalServices team in the US with the news that Sharp Bethlehem has concluded a successful FDA audit. Watch our video to learn about #SharpClinical - your partner of choice for end-to-end supply chain solutions.
#ClinicalTrials #OurWorkMatters

UDG Healthcare CEO Awards – Celebrating excellence and recognising our people. @UDGHealthcare #CEOAwards #LivingOurValues